A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy - The SUMMIT Trial
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2015
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Allergic rhinitis
- Focus Therapeutic Use
- Acronyms SUMMIT
- Sponsors ALK-Abello
- 20 Jan 2014 Status changed from active, no longer recruiting to completed as reported by the ClinicalTrials.gov record.
- 15 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 19 Dec 2012 New trial record